iCAD Completes Buy of VuCOMP’s Cancer Detection Portfolio
Advanced image analysis and radiation therapy provider iCAD has completed the acquisition of VuCOMP’s cancer detection portfolio for an undisclosed sum.
VuCOMP develops advanced computer applications for the detection of breast cancer. iCAD has picked up a library of related clinical data with the acquisition.
It also has gained VuCOMP's key personnel and existing customer base, as well as its M-Vu computer-aided detection technology platform.
iCAD purchased VuCOMP's M-Vu Breast Density software product in April 2015. — Michael Cipriano